Published in J Rheumatol on February 01, 1993
Chronic intestinal pseudo-obstruction in patients with systemic lupus erythematosus: report of four cases. Clin Rheumatol (2007) 1.18
Intestinal pseudo-obstruction: initial manifestation of systemic lupus erythematosus. J Neurogastroenterol Motil (2011) 1.03
Lupus enteritis: from clinical findings to therapeutic management. Orphanet J Rare Dis (2013) 1.00
Chronic intestinal pseudo-obstruction in systemic lupus erythematosus. Gut (1998) 0.99
Visceral muscle dysmotility syndrome in systemic lupus erythematosus: case report and review of the literature. Rheumatol Int (2011) 0.89
Primary intestinal autoimmune disease as a cause of chronic intestinal pseudo-obstruction. Gut (2005) 0.75
Intestinal Pseudo-Obstruction as an Initial Manifestation of Systemic Lupus Erythematosus. Intest Res (2015) 0.75
Acute lupus pneumonitis followed by intestinal pseudo-obstruction in systemic lupus erythematosus: A case report. Exp Ther Med (2016) 0.75
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet (1997) 10.05
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet (2001) 5.82
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology (1999) 5.55
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78
Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) (1996) 4.52
Cultivation of the bacillus of Whipple's disease. N Engl J Med (2000) 3.97
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Liver fibrosis in overweight patients. Gastroenterology (2000) 3.56
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum (1999) 3.20
Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med (1997) 3.01
Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Ann Rheum Dis (2004) 2.95
Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys (2000) 2.58
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet (1992) 2.51
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology (1999) 2.36
Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) (2000) 2.35
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol (2006) 2.28
The key role of nucleosomes in lupus. Arthritis Rheum (1999) 2.26
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology (1996) 2.22
Functional results after extended myotomy for diffuse oesophageal spasm. Br J Surg (2007) 2.20
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology (1999) 2.18
Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology (1999) 2.11
Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med (1996) 2.10
Hepatitis C virus and essential mixed cryoglobulinaemia. Br J Rheumatol (1993) 2.08
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Whipple disease. Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Société Nationale Française de Médecine Interne. Medicine (Baltimore) (1997) 1.97
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther (2005) 1.95
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report. Gut (2000) 1.94
Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria. J Rheumatol (1992) 1.94
Cefotaxime-related hypoprothrombinemia in a patient with acute pancreatitis: a case with a possible clue to the pathogenesis. Am J Gastroenterol (1989) 1.92
Arterial lesions in Behçet's disease. A study in 25 patients. J Rheumatol (1995) 1.85
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med (2008) 1.84
Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum (1999) 1.77
Biliary obstruction caused by portal cavernoma: a study of 8 cases. J Hepatol (1996) 1.74
Profiling and classification tree applied to renal epithelial tumours. Histopathology (2007) 1.71
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology (1994) 1.69
Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum (1999) 1.67
Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut (1999) 1.67
Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr (2005) 1.66
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat (2005) 1.64
Immune complex type glomerulonephritis in cirrhosis of the liver. Am J Pathol (1975) 1.63
Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci (1989) 1.63
Histologic aspects of pulmonary barotrauma in critically ill patients with acute respiratory failure. Intensive Care Med (1993) 1.63
Pacemaker infective endocarditis. Am J Cardiol (1998) 1.62
Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol (2000) 1.61
Enhancement of mRNA in situ hybridization signal by microwave heating. Lab Invest (1995) 1.59
Multiple pulmonary arterial aneurysms in Behcet's disease and Hughes-Stovin syndrome. Am J Med (1981) 1.58
Minimal change nephrotic syndrome revealing solid tumors. Nephron (1992) 1.58
Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation (2000) 1.58
Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol (1988) 1.56
Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum (1997) 1.55
Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) (1990) 1.55
Intractable hiccup as the initial presenting feature of systemic lupus erythematosus. Lupus (2005) 1.53
Nonsteroidal anti-inflammatory drug-induced colonic strictures: two cases and literature review. Am J Gastroenterol (1995) 1.53
Interferon for acute hepatitis C. Cochrane Database Syst Rev (2002) 1.52
Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum (2000) 1.52
Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2001) 1.52
Association of hepatic vein obstruction and coeliac disease in North African subjects. J Hepatol (1994) 1.51
The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature. Medicine (Baltimore) (1995) 1.51
Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol (2001) 1.49
Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med (1991) 1.49
A national survey of endoscopic mucosal resection for superficial gastrointestinal neoplasia. Endoscopy (2010) 1.49
Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis. J Immunol (1990) 1.47
Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival. Gastroenterology (2000) 1.47
A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol (2001) 1.46
Chloroquine-quinacrine association in resistant cutaneous lupus. Dermatology (1995) 1.46
Urinary trypsin inhibitory activity for the diagnosis of bacterial infection: a prospective study in 690 patients. Eur J Med (1992) 1.45
Cerebral venous thrombosis in systemic lupus erythematosus. Stroke (1990) 1.45
Endoscopic submucosal dissection in a European setting. A multi-institutional report of a technique in development. Endoscopy (2011) 1.44
Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Lupus (1995) 1.44
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut (1999) 1.44
The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol (1999) 1.44
Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Aliment Pharmacol Ther (2002) 1.43
Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) (2001) 1.43
A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis Rheum (2001) 1.43
T lymphocyte subsets in primary antiphospholipid syndrome. J Rheumatol (1994) 1.43
Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res (2000) 1.43
Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum (1997) 1.42
Late pancreatic metastasis from renal cell carcinoma diagnosed by endoscopic ultrasonography. Surgery (1995) 1.42
Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity? Am J Gastroenterol (2001) 1.42
Ischemic Vernet's syndrome in giant cell arteritis: first two cases. Am J Med (1992) 1.41